Cutler Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,300
| Closed | -$6K | – | 5821 |
|
|
2020
Q3 | $6K | Buy |
+4,300
| New | +$217K | ﹤0.01% | 3441 |
|
|
2020
Q2 | – | Sell |
-8,500
| Closed | -$10K | – | 5157 |
|
|
2020
Q1 | $10K | Sell |
8,500
-16,000
| -65% | -$269K | ﹤0.01% | 2743 |
|
|
2019
Q4 | $1K | Buy |
24,500
+8,500
| +53% | +$150K | ﹤0.01% | 3861 |
|
|
2019
Q3 | $20K | Hold |
16,000
| – | – | ﹤0.01% | 2197 |
|
|
2019
Q2 | $27K | Sell |
16,000
-5,000
| -24% | -$75.2K | ﹤0.01% | 2002 |
|
|
2019
Q1 | $20K | Buy |
21,000
+18,600
| +775% | +$300K | ﹤0.01% | 2073 |
|
|
2018
Q4 | $6K | Sell |
2,400
-500
| -17% | -$9.93K | ﹤0.01% | 2881 |
|
|
2018
Q3 | $11K | Hold |
2,900
| – | – | ﹤0.01% | 2625 |
|
|
2018
Q2 | $10K | Sell |
2,900
-2,500
| -46% | -$50.2K | ﹤0.01% | 2698 |
|
|
2018
Q1 | $21K | Sell |
5,400
-23,800
| -82% | -$389K | ﹤0.01% | 2271 |
|
|
2017
Q4 | $22K | Buy |
29,200
+1,300
| +5% | +$15.3K | ﹤0.01% | 2504 |
|
|
2017
Q3 | $3K | Sell |
27,900
-1,400
| -5% | -$14K | ﹤0.01% | 4934 |
|
|
2017
Q2 | $5K | Sell |
29,300
-5,800
| -17% | -$40.7K | ﹤0.01% | 4922 |
|
|
2017
Q1 | $17K | Buy |
+35,100
| New | +$178K | ﹤0.01% | 3523 |
|
|
2016
Q3 | – | Sell |
-1,000
| Closed | -$2K | – | 7667 |
|
|
2016
Q2 | $2K | Buy |
+1,000
| New | +$3.34K | ﹤0.01% | 5847 |
|
|
2016
Q1 | – | Sell |
-14,700
| Closed | -$67K | – | 7504 |
|
|
2015
Q4 | $67K | Buy |
+14,700
| New | +$41K | ﹤0.01% | 2165 |
|
Cutler Group's IMMU Position: Q4 2020 in Review
Cutler Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 19,900 shares — an estimated $1.69M sold.
Cutler Group first reported a position in IMMU in Q4 2015 and held it in 14 quarters. The position peaked at $1.69M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Cutler Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Cutler Group sold 19,900 Immunomedics Inc shares in Q4 2020, an estimated $1.69M.
- Cutler Group first reported a position in Immunomedics Inc in Q4 2015 and held it in 14 quarters.
- Cutler Group's Immunomedics Inc position peaked at $1.69M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.